| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 92566 |
月桂酸(C12)-PEG-卵黄高磷蛋白(Pv) |
248 |
h |
2024-11-22 |
| 92567 |
CMCTS-SS-C16 含脂肪链的还原响应两亲性壳聚糖 |
222 |
h |
2024-11-22 |
| 92568 |
C16-SS-PEG/DMMA，棕榈酸-二硫键-聚乙二醇-甲基丙烯酸甲酯单体 |
223 |
h |
2024-11-22 |
| 92569 |
dota-ingr DOTA耦合新生血管靶向肽iNGR dota-gggcrngrgpdc |
136 |
zcy |
2024-11-22 |
| 92570 |
DOTA-GGG-TMVP1 DOTA修饰GGG-TMVP1靶向肽 |
171 |
zcy |
2024-11-22 |
| 92571 |
PL-A2-DOTA-Gd 天冬氨酸-亮氨酸共聚物偶联钆-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(Gd-DOTA) |
127 |
zcy |
2024-11-22 |
| 92572 |
Pteroyl-lys-DOTA DOTA修饰蝶酰赖氨酸 |
139 |
zcy |
2024-11-22 |
| 92573 |
靶向VEGF载PTX聚合物纳米粒 Target PTX-loaded nanoparticles TPN |
212 |
zcy |
2024-11-22 |
| 92574 |
DOTA-PEG(12)-TFP*2TFA |
136 |
kx |
2024-11-22 |
| 92575 |
gadolinium Cy(2)DOTA |
112 |
kx |
2024-11-22 |
| 92576 |
NOTA-E(cRGDfK)2双功能螯合物 |
151 |
zyl |
2024-11-22 |
| 92577 |
DOTA-D-Glu-Ala-Tyr-Gly-Trp-(N-Me)Nle-Asp-1Nal-NH2 |
148 |
kx |
2024-11-22 |
| 92578 |
多肽化合物DOTA-RGD |
160 |
zyl |
2024-11-22 |
| 92579 |
DOTA-DG 葡萄糖胺-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
179 |
zcy |
2024-11-22 |
| 92580 |
CAS：1426155-87-4， CU-64 DOTA-TATE |
142 |
kx |
2024-11-22 |
| 92581 |
氰基-半胱氨酸(CN-Cys) |
213 |
zcy |
2024-11-22 |
| 92582 |
DOTA-ubiquicidin (29–41) |
149 |
kx |
2024-11-22 |
| 92583 |
p-NO2-Bn-DOTA，116052-88-1 |
145 |
zyl |
2024-11-22 |
| 92584 |
C18烷基链-超支化聚甘油接枝p-环糊精两亲性聚阳离子囊泡 C18-γ-CD-HPG |
155 |
h |
2024-11-22 |
| 92585 |
TM-DOTA |
141 |
kx |
2024-11-22 |
| 92586 |
v6肽-NHCO-PEG-NHCO棕榈酰胺两亲性聚合物(v6-PEG-C16) |
192 |
h |
2024-11-22 |
| 92587 |
DOTA-NHS-ester，170908-81-3 |
159 |
zyl |
2024-11-22 |
| 92588 |
DOTA-Tyr-Lys-DOTA |
152 |
kx |
2024-11-22 |
| 92589 |
DOTA-peptide DOTA修饰磷酸化环腺苷酸应答元件结合蛋白(多肽) |
177 |
zcy |
2024-11-22 |
| 92590 |
功能性聚合物脂质 polyethylene glycol-Gly-Leu-Phe-Gly-Lys(C16)2) |
134 |
h |
2024-11-22 |
| 92591 |
DOTA-Colchicine |
141 |
zyl |
2024-11-22 |
| 92592 |
BAC14聚肌氨酸叠氮化物 BAC14-polysarcosine-Azide |
268 |
h |
2024-11-22 |
| 92593 |
CAS：204318-14-9，依多曲肽，DOTA-(Tyr3)-Octreotide acetate salt |
154 |
kx |
2024-11-22 |
| 92594 |
PEG-P(C16, BLA) 十六烷基聚(乙二醇)-聚(β-苄基l-天冬氨酸) |
204 |
h |
2024-11-22 |
| 92595 |
DOTA-PLL的介绍 |
158 |
zyl |
2024-11-22 |
| 92596 |
DOTA-E-[cyclo(RGDfK(Acp))]2 |
137 |
kx |
2024-11-22 |
| 92597 |
DOTA-Biotin DOTA-生物素 |
135 |
zyl |
2024-11-22 |
| 92598 |
DOTA-ZHER2:342(Cys39) 大环DOTA修饰anti-EGFR亲和体分子 |
152 |
zcy |
2024-11-22 |
| 92599 |
C16-PEG(2000Da)-Ceramide，C16 PEG2000神经酰胺 |
301 |
h |
2024-11-22 |
| 92600 |
DOTA-PEG-DBCO 点击化学聚乙二醇大环配体 |
154 |
zyl |
2024-11-22 |
| 92601 |
CAS：834870-39-2， 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 10-(2,3,4,5,6-pentafluorophenyl) ester |
138 |
kx |
2024-11-22 |
| 92602 |
PSI-mPEG-C16 聚琥珀酰亚胺-甲氧基聚乙二醇-十六胺 |
235 |
h |
2024-11-22 |
| 92603 |
羧基化聚乙二醇单甲醚(mPEG-COOH) |
332 |
zcy |
2024-11-22 |
| 92604 |
cas：2032239-75-9|Maleimido-mono-amide-DTPA|马来酰亚胺单酰胺-DTPA |
182 |
zyl |
2024-11-22 |
| 92605 |
GdHPDO3A-C16，具有C16烷基链的HPDO3A配体 |
189 |
h |
2024-11-22 |
| 92606 |
819869-77-7,DOTA-(COOt-Bu)3-NHS,DOTA-三叔丁酯活性酯 |
142 |
zyl |
2024-11-22 |
| 92607 |
Gd-DOTA-AGCMC6 大分子多糖阿拉伯半乳聚糖修饰的DOTA钆配合物 |
130 |
zcy |
2024-11-22 |
| 92608 |
Gd-DOTA(M-147)的主要组成成分及功能 |
184 |
kx |
2024-11-22 |
| 92609 |
DOTA-RGD tetramer DOTA偶联RGD四聚体 |
136 |
zcy |
2024-11-22 |
| 92610 |
cas:1262403-90-6 DOTA-Val-Leu-Ala-Ser-Ser-Ala-Arg-COOH |
140 |
zyl |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询